Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
2018 1
2020 2
2021 22
2022 26
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infections.
Chemaitelly H, Ayoub HH, AlMukdad S, Faust JS, Tang P, Coyle P, Yassine HM, Al Thani AA, Al-Khatib HA, Hasan MR, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Chemaitelly H, et al. Among authors: latif an. J Travel Med. 2023 Sep 5;30(5):taad106. doi: 10.1093/jtm/taad106. J Travel Med. 2023. PMID: 37555656 Free PMC article.
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic.
Abu-Raddad LJ, Chemaitelly H, Ayoub HH, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Owen RC, Rahim HFA, Al Abdulla SA, Al Kuwari MG, Kandy MC, Saeb H, Ahmed SNN, Al Romaihi HE, Bansal D, Dalton L, Al-Thani MH, Bertollini R. Abu-Raddad LJ, et al. Among authors: latif an. Sci Rep. 2021 Mar 18;11(1):6233. doi: 10.1038/s41598-021-85428-7. Sci Rep. 2021. PMID: 33737535 Free PMC article.
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar.
Abu-Raddad LJ, Chemaitelly H, Bertollini R; National Study Group for COVID-19 Vaccination. Abu-Raddad LJ, et al. N Engl J Med. 2022 Feb 24;386(8):799-800. doi: 10.1056/NEJMc2117933. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045222 Free PMC article. No abstract available.
Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar.
Abu-Raddad LJ, Chemaitelly H, Bertollini R; National Study Group for COVID-19 Vaccination. Abu-Raddad LJ, et al. N Engl J Med. 2022 Mar 17;386(11):1091-1093. doi: 10.1056/NEJMc2119432. Epub 2022 Jan 26. N Engl J Med. 2022. PMID: 35081294 Free PMC article. No abstract available.
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2.
Chemaitelly H, Ayoub HH, Tang P, Hasan MR, Coyle P, Yassine HM, Al-Khatib HA, Smatti MK, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Chemaitelly H, et al. Among authors: latif an. N Engl J Med. 2022 Nov 3;387(18):1716-1718. doi: 10.1056/NEJMc2211055. Epub 2022 Oct 12. N Engl J Med. 2022. PMID: 36223534 Free PMC article. No abstract available.
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.
Altarawneh HN, Chemaitelly H, Hasan MR, Ayoub HH, Qassim S, AlMukdad S, Coyle P, Yassine HM, Al-Khatib HA, Benslimane FM, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Tang P, Abu-Raddad LJ. Altarawneh HN, et al. Among authors: latif an. N Engl J Med. 2022 Mar 31;386(13):1288-1290. doi: 10.1056/NEJMc2200133. Epub 2022 Feb 9. N Engl J Med. 2022. PMID: 35139269 Free PMC article. No abstract available.
Covid-19 Vaccine Protection among Children and Adolescents in Qatar.
Chemaitelly H, AlMukdad S, Ayoub HH, Altarawneh HN, Coyle P, Tang P, Yassine HM, Al-Khatib HA, Smatti MK, Hasan MR, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Al-Romaihi HE, Butt AA, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Chemaitelly H, et al. Among authors: latif an. N Engl J Med. 2022 Nov 17;387(20):1865-1876. doi: 10.1056/NEJMoa2210058. Epub 2022 Nov 2. N Engl J Med. 2022. PMID: 36322837 Free PMC article.
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
Abu-Raddad LJ, Chemaitelly H, Malek JA, Ahmed AA, Mohamoud YA, Younuskunju S, Ayoub HH, Al Kanaani Z, Al Khal A, Al Kuwari E, Butt AA, Coyle P, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul Rahim HF, Yassine HM, Al Kuwari MG, Al Romaihi HE, Al-Thani MH, Bertollini R. Abu-Raddad LJ, et al. Among authors: latif an. Clin Infect Dis. 2021 Oct 5;73(7):e1830-e1840. doi: 10.1093/cid/ciaa1846. Clin Infect Dis. 2021. PMID: 33315061 Free PMC article.
Protection against Reinfection with the Omicron BA.2.75 Subvariant.
Chemaitelly H, Tang P, Coyle P, Yassine HM, Al-Khatib HA, Smatti MK, Hasan MR, Ayoub HH, Altarawneh HN, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ; National Study Group for COVID-19 Epidemiology. Chemaitelly H, et al. Among authors: latif an. N Engl J Med. 2023 Feb 16;388(7):665-667. doi: 10.1056/NEJMc2214114. Epub 2023 Jan 18. N Engl J Med. 2023. PMID: 36652342 Free PMC article. No abstract available.
Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease.
Bansal D, Abdulmajeed J, Al-Shamali MHMA, Albayat SSA, Himatt SM, Cyprian FS, Chivese T, Mundodan JMA, Khogali HS, Baaboura R, Kaleeckal AH, Kandy MC, Latif AN, Al-Kuwari MG, Al-Romaihi HE, Al Khal A, Bertollini R, Al-Thani MH, Farag E, Doi SAR. Bansal D, et al. Among authors: latif an. Vaccines (Basel). 2022 Jun 28;10(7):1036. doi: 10.3390/vaccines10071036. Vaccines (Basel). 2022. PMID: 35891199 Free PMC article.
66 results